Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice

Masafumi Kuzuya1, Kae Nakamura, Takeshi Sasaki

  • 1Department of Geriatrics, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. kuzuya@med.nagoya-u.ac.jp

Abstract

Insights

Matrix metalloproteinase (MMP)-2 plays a key role in atherosclerosis plaque development. MMP-2 deficiency significantly reduced atherosclerotic lesions in apolipoprotein E-deficient mice, indicating its contribution to the disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Atherosclerosis Research

Background:

  • Matrix metalloproteinase (MMP)-2 is implicated in atherosclerotic plaque pathogenesis.
  • Direct evidence for MMP-2's role in lesion formation is lacking.

Purpose of the Study:

  • To investigate the specific role of MMP-2 in the development of atherosclerosis.
  • To utilize apolipoprotein E-deficient (apoE(-/-)) mice as a model system.

Main Methods:

  • Generated MMP-2-deficient, apoE-deficient (MMP-2(-/-):apoE(-/-)) mice by crossing MMP-2(-/-) with apoE(-/-) mice.
  • Fed mice a lipid-rich diet for 8 weeks.
  • Conducted morphological and biochemical analyses of the aortic sinus and arch.

Main Results:

  • MMP-2 deficiency significantly reduced atherosclerotic plaque size in the aortic sinus and arch.
  • Observed decreased smooth muscle cell-positive areas in MMP-2 deficient mice.
  • Found lower expression of TIMP-1 and TIMP-2 mRNA in atherosclerotic lesions of MMP-2 deficient mice.

Conclusions:

  • MMP-2 is a significant contributor to atherosclerosis development in apoE(-/-) mice.
  • Targeting MMP-2 may offer therapeutic potential for atherosclerosis.